Development of an antidiabetic formulation (ADJ6) and its inhibitory activity against α-amylase and α-glucosidase.

Saved in:
Bibliographic Details
Title: Development of an antidiabetic formulation (ADJ6) and its inhibitory activity against α-amylase and α-glucosidase.
Authors: Duraiswamy A; Department of Cellular and Molecular Biochemistry, Frontier Mediville (A Unit of Frontier Lifeline and Dr. K. M. Cherian Heart Foundation), Affiliated to University of Madras, Chennai, Tamil Nadu, India., Shanmugasundaram D; Department of Cellular and Molecular Biochemistry, Frontier Mediville (A Unit of Frontier Lifeline and Dr. K. M. Cherian Heart Foundation), Affiliated to University of Madras, Chennai, Tamil Nadu, India., Sasikumar CS; Department of Cellular and Molecular Biochemistry, Frontier Mediville (A Unit of Frontier Lifeline and Dr. K. M. Cherian Heart Foundation), Affiliated to University of Madras, Chennai, Tamil Nadu, India., Cherian SM; Department of Cardiothoracic Surgery, Frontier Lifeline Hospital, Chennai, Tamil Nadu, India., Cherian KM; Department of Cardiothoracic Surgery, Frontier Lifeline Hospital, Chennai, Tamil Nadu, India.
Source: Journal of traditional and complementary medicine [J Tradit Complement Med] 2015 Feb 28; Vol. 6 (3), pp. 204-8. Date of Electronic Publication: 2015 Feb 28 (Print Publication: 2016).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V. on behalf of the Center for Food and Biomolecules, National Taiwan University Country of Publication: Netherlands NLM ID: 101605474 Publication Model: eCollection Cited Medium: Print ISSN: 2225-4110 (Print) Linking ISSN: 22254110 NLM ISO Abbreviation: J Tradit Complement Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2225-4110
DOI:10.1016/j.jtcme.2014.12.006